Diabetes patients at higher risk of developing postoperative endophthalmitis after cataract surgery: Study Dr Riya Dave7 May 2025 8:00 AM ISTResearchers have found in a new study that patients with diabetes undergoing cataract surgery face a significantly higher risk of postoperative...
Study Warns of Rising Hypertension and Diabetes Cases in Raipur Slum: Urges Early Screening Medha Baranwal17 April 2025 8:00 PM ISTIndia: A recent retrospective record-based study conducted in an urban slum of Chhattisgarh has highlighted the significant prevalence of hypertension...
Sarcopenic Obesity Linked to Worse Heart Failure Outcomes in Diabetic Patients: Study Finds Medha Baranwal17 March 2025 9:00 AM ISTChina: A recent study highlights the potential risks associated with sarcopenic obesity (SO) in diabetic patients with heart failure with reduced...
Hetero Labs Gets CDSCO Panel Nod To study Semaglutide Injection for Type 2 Diabetes Mellitus Dr. Divya Colin10 March 2025 6:00 PM ISTNew Delhi: Hetero Labs has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization...
Alkem Laboratories Gets CDSCO Panel Nod To study Semaglutide tablet for Type 2 Diabetes Mellitus Dr. Divya Colin9 March 2025 6:00 PM ISTNew Delhi: Alkem Laboratories has got the go ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO Panel Rejects Novo Nordisk Proposal to amend warning statement of Semaglutide Injection Dr. Divya Colin8 March 2025 5:15 PM ISTNew Delhi: Noting that post-marketing safety data in Indian patients is not presented, the Subject Expert Committee (SEC) functional under the Central...
CDSCO Panel approves Zydus Lifesciences to study Semaglutide Injection Dr. Divya Colin28 Feb 2025 6:00 PM ISTNew Delhi: Accepting the bioequivalence study report for Type 2 Diabetes Mellitus, the Subject Expert Committee (SEC) functional under the Central...
Retinal examination be done at each visit: CDSCO Panel tells Alkem Lab on Semaglutide Injection Phase III CT study Dr. Divya Colin15 Feb 2025 6:00 PM ISTNew Delhi: Considering the bioequivalence study report of Semaglutide Injection 2 mg presented by the drug major Alkem Laboratories, the Subject...
Empagliflozin Reduces CI-AKI Risk in PCI Patients by Improving Renal Function: Study Reveals Medha Baranwal8 Feb 2025 5:15 AM ISTIran: A recent randomized trial has highlighted the potential of empagliflozin in reducing the risk of contrast-induced acute kidney injury (CI-AKI)...
Proteinuria Linked to Increased Risk of Atrial Fibrillation Across All Glycemic Stages: Study Finds Medha Baranwal3 Feb 2025 8:00 AM ISTSouth Korea: A recent nationwide population-based cohort study has shed light on the significant relationship between proteinuria and the risk of...
Acute Pancreatitis in Youth Linked to Diabetes Risk: Study Identifies Key Predictors Medha Baranwal21 Dec 2024 8:45 AM ISTUSA: A study published in Digestive and Liver Disease suggests that youths who experience acute pancreatitis may face an increased risk of developing...
Diabetes management: Cipla bags CDSCO regulatory nod for distribution, marketing of Afrezza (insulin human) Inhalation Powder in India Ruchika Sharma12 Dec 2024 1:30 PM ISTMumbai: Cipla Limited has announced that it has obtained regulatory approval from Central Drugs Standard Control Organisation (CDSCO) for the...
